Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
Royal National Orthopaedic Hospital NHS Trust
Brockley Hill
Stanmore
HA7 4LP
UK
Contact person: Stephen Marshman
E-mail: stephen.marshman@nhs.net
NUTS: UKI74
Internet address(es)
Main address: https://www.rnoh.nhs.uk
Address of the buyer profile: https://www.rnoh.nhs.uk
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Specialist Radiology Reporting Services
II.1.2) Main CPV code
85150000
II.1.3) Type of contract
Services
II.1.4) Short description
Specialist radiology reporting for sarcoma and complex spines . RNOH is one of five hospitals designated as a Joint Soft Tissue and Bone Sarcoma MDT Provider in England. This is an NHS tertiary service requiring experience and qualified staff.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
300 000.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
85100000
II.2.3) Place of performance
NUTS code:
UKI74
II.2.4) Description of the procurement
The intention is to award a contract under Direct Award C under the Provider Selection Regime. The estimated value of the contract is £300,000.<br/><br/>The Royal National Orthopaedic NHS Trust (RNOH) has been delegated by NHS England to provide specialist sarcoma services in line with the national service specification. RNOH is one of five hospitals designed as Joint Soft Tissue and Bone Sarcoma MDT Provider in England. This is an NHS tertiary service. The service follows the national service specification which can be viewed here: NHS commissioning » Sarcoma Services (all ages) (england.nhs.uk)<br/><br/>This service requires appropriately trained and experienced radiologists who can support the hospital to meet the terms of the specification. Principally this is reporting on scans related to soft tissue and bone sarcoma in a timely and accurate manner. This is a highly specialised area with specific experience required.
II.2.5) Award criteria
Cost criterion: the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard
/ Weighting: 100
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 13th October 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
30/09/2026
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Stanmore Orthopaedic Imaging Solutions LLP
OC453310
12 Magnolia Drive
Watford
WD23 4AH
UK
NUTS: UKH2
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
Lowest offer:
300 000.00
GBP
/ Highest offer:
300 000.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 13th October 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.<br/><br/>The decision makers:<br/>* James Brennan, Senior Operational Manager, Imaging, RNOH<br/>* Stephen Marshman, Head of Contracts, RNOH<br/><br/>No conflicts of interest were identified among the decision makers.<br/><br/>Having considered the Basic Selection Criteria and the five key criteria required under the Provider Selection Regime, the assessment concludes that the incumbent provider continues to demonstrate the capability, expertise, integration and value required to deliver the specialised sarcoma and bone tumour radiology reporting service. Accordingly, it is recommended that the contract be awarded under Direct Award Process C.<br/><br/>Contact: stephen.marshman@nhs.net / james.brennan10@nhs.net
VI.4) Procedures for review
VI.4.1) Review body
Independent patient choice and procurement panel
Wellington House
London
SE1 8UG
UK
VI.5) Date of dispatch of this notice
01/10/2026